Key Indicators of Value & Success in a Life Science Company: What Investors Look For
30 September 2009
Venture Capital and strategic investors value new and emerging life science companies differently in these challenging times. Entrepreneurs have been forced to modify business plans to stay afloat, while investors have taken a different approach to determining a life science company’s value.
This session will cover long-term strategies that emerging life science businesses should consider when seeking investors, while highlighting opportunities for investors in discovering and creating sustainable value.
-
Diverse perspectives from angel investors to mid-tier funds
-
Issues and perspective from the entrepreneur’s view
-
State of the venture and strategic markets and current trends
-
Factors to be considered in determining the investment opportunities and future returns of life science companies
-
The role of IP in value creation
-
Understanding market opportunities and constraints
Panelists:
-
Gabor Garai, Partner, Foley & Lardner LLP
-
Patrick Heron, General Partner, Frazier Healthcare Ventures
-
Jay S. Kunin, Ph.D., Vice President, TechCoast Angels
-
Bill Molloie, Partner, San Diego Life Sciences Lead, Pricewaterhouse Coopers
-
Hans Petersen, CEO, Traversa Therapeutics
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.